Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

michael_boyd

Gilead appoint Pfizer and AbbVie veteran as VP of governmental affairs

November 13, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

American antiviral drug specialist Gilead have appointed Pfizer and AbbVie veteran Michael Boyd as VP of government affairs and policy …
Appointment

Working Life: Philippe Bastide, Head of Biosimilars, Mundipharma

November 12, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Mundipharma, Philippe Bastide, biosimilars, leukaemia

“Don’t conform to what people want – take risks. The people who make a big difference are the ones who …
Feature
astrazeneca_building_white

AZ’s Farxiga shows strength in largest ever SGLT2 inhibitor cardiovascular outcomes study

November 12, 2018 Research and Development, Sales and Marketing AstraZeneca, cardiovascular, farxiga, pharma

AstraZeneca has revealed new data for its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin) at the American Heart Association (AHA) …
News
dave_tudor

GSK veteran Dave Tudor joins MMIC in Scotland

November 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Scotland, dave tudor, life sciences, manufacturing

GlaxoSmithKline veteran, Dave Tudor, is set to take on the role of Managing Director of the Medicines Manufacturing Innovation Centre …
Appointment
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Celgene, GSK, Novo Nordisk, politics, popular, top 10, vaccines

The biggest news this week came from Israeli biotech Zion Medical after it was announced that HIV drug Gammora was …
News
helena-baker

Living with fibular hemimelia

November 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cambridge rare disease network, diagnosis, fibular hemimelia, rare disease, therapy

Helena Baker, Vice President of Clinical Strategy at Medical Research Network and a trustee of the newly formed Rare Disease …
Feature
shutterstock_gonnorrhea

Investigational antibiotic shows high cure rates in gonorrhoea at Phase 2

November 8, 2018 Research and Development National Institute of Allergy and Infectious Diseases, National Institutes of Health, gonorrhoea, pharma, zoliflodacin

A Phase 2 study sponsored by The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National …
News
staphylococcus_aureus_visa

AMR superbugs expected to kill 90,000 Britons in the next 30 years

November 8, 2018 Research and Development AMR, antimicrobial resistance, infectious diseases, spanish flu

Antibiotic resistant superbugs will kill more than 90,000 British people over the next thirty years if action is not taken …
News
bicycle_therapeutics

Bicycle Therapeutics picks up former Pfizer head as new SVP of Pre-Clinical Development

November 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Cambridge based biotechnology firm Bicycle therapeutics, has announced former Pfizer head Dr Phil Jeffrey as the company’s new Senior …
Appointment
jeanette_kusel

NICE appoints experienced pharma consultant as Director of NICE Scientific Advice

November 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, government, national institute of health and care excellence, politics, sciences

The National Institute for Health and Care Excellence (NICE) has appointed Jeanette Kusel as Director of NICE Scientific Advice. The …
Appointment
787px-prostate_normal_1

Prostate cancer researchers win $2m to explore carboplatin therapy

November 7, 2018 Research and Development Cancer, carboplatin therapy, prostate cancer

The US Department of Defence has awarded a coalition of researchers – made up of the Prostate Cancer Clinical Research …
News

Former Celgene CEO Bob Hugin loses in US midterm elections

November 7, 2018 Research and Development Bob Hugin, Celgene, Trump, midterms, republican, us politics

Former Celgene CEO Bob Hugin has failed in his bid to win over the people of New Jersey, after voters …
News

FDA approves BMS’ multiple myeloma combo after it doubles progression-free survival

November 7, 2018 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Empliciti, FDA, US, multiple myeloma, pharma

The FDA has seen fit to approve Bristol-Myers Squibb’s Empliciti (elotuzumab) intravenous injection in combination with pomalidomide and dexamethasone for …
News
lilly_building_with_american_flag_web

Lilly’s Trulicity reduces major cardiovascular events in “ambitious” trial of type 2 diabetes

November 7, 2018 Research and Development Eli Lilly, Trulicity, cardiovascular events, pharma, type 2 diabetes

Eli Lilly has revealed new data on Trulicity (dulaglutide), showing that glucagon-like peptide-1 (GLP-1) receptor agonist achieved its primary endpoint …
News
sewage-pipe-polluted-water-3465090_960_720

Very high concentrations of pharmaceuticals found in animals in Australian streams

November 7, 2018 Research and Development Contamination, ecosystems, environment, pharmaceuticals, pollution

More than 60 different pharmaceutical compounds were detected in aquatic invertebrate larvae and riparian predators in six streams near Melbourne, …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026